Figure 1.

SEC61G is overexpressed in liver cancer and is associated with the survival time of patients. (a) The expression of SEC61G in liver cancer was significantly higher than that in paracancerous tissue by analyses from TCGA database. Number of tumor tissues was 369 and that of non-tumor tissues was 160. (b) SEC61G expression was negatively associated with survival time of patients. (c) IHC assay for tissue microarray paraffin blocks of HCC patients (N = 85) showed that SEC61G was also up-regulated in tumor tissues compared to paracancerous tissues. *** P < 0.01 compared with paracancerous tissues